首页> 美国卫生研究院文献>Lupus Science Medicine >Original research article: Analysis of relationships between 25-hydroxyvitamin D parathyroid hormone and cathelicidin with inflammation and cardiovascular risk in subjects with paediatric systemic lupus erythematosus: an Atherosclerosis Prevention in Paediatric Lupus Erythematosus (APPLE) study
【2h】

Original research article: Analysis of relationships between 25-hydroxyvitamin D parathyroid hormone and cathelicidin with inflammation and cardiovascular risk in subjects with paediatric systemic lupus erythematosus: an Atherosclerosis Prevention in Paediatric Lupus Erythematosus (APPLE) study

机译:原始研究文章:小儿系统性红斑狼疮患者中25-羟基维生素D甲状旁腺激素和cathelicidin与炎症和心血管风险的关系分析:预防小儿红斑狼疮的动脉粥样硬化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectivesPrevious studies demonstrated associations between reduced serum 25-hydroxyvitamin D (25OHD), inflammation and disease activity in paediatric systemic lupus erythematosus (pSLE). The goal of this study was to assess parathyroid hormone (PTH) in its relationship to vitamin D and inflammation, as well as to better understand the role of human cathelicidin (LL-37) in pSLE.
机译:目的以前的研究表明小儿系统性红斑狼疮(pSLE)的血清25-羟基维生素D(25OHD)减少与炎症和疾病活动之间存在关联。这项研究的目的是评估甲状旁腺激素(PTH)与维生素D和炎症的关系,以及更好地了解人导管素(LL-37)在pSLE中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号